EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/307221
The Only Lens in the U.S. Designed for True 1.8 mm MICS ™ Learn more about Akreos ® MICS ™ and the benefi ts of 1.8 mm surgery at www.bauschsurgical.com/MICS References: 1. Erie JC, Bandhauer MH, McLaren JW. Analysis of postoperative glare and intraocular lens design. J Cataract Refract Surg. 2001;27 (4):614 - 621. 2. Barrett, G and Carlsson, A . Cataract Surgical Wound Strength In Vivo. COS annual meeting and exhibition, 2007, Montreal, Canada. 3. Zafi rakis, P. Microincision Cataract Surgery. Stellaris Phaco Platform Versus Infi niti Torsional Ultrasound Phaco Mode: Randomized Comparative Clinical Study. ASCRS Symposium on Cataract, IOL and Refractive Surgery, 2009, San Francisco, Calif. ©2011 Bausch & Lomb Incorporated. ™/ ® denote trademarks of Bausch & Lomb Incorporated. SU5556 2/11 MICS Benefi ts Reduction in surgically induced astigmatism 1 Increased wound sealability 2 Reduction in endothelial cell loss 3 INDICATIONS: Akreos® posterior chamber lenses are indicated for primary implantation for the visual correction of aphakia in adult patients where a cataractous lens has been removed by phacoemulsifi cation. The lens is intended for placement in the capsular bag. CONTRAINDICATIONS: Implantation is not advisable when the IOL may aggravate an existing condition, interfere with the diagnosis or the treatment of a pathology, or present a risk to the sight of the patient. These conditions are uncontrolled glaucoma, rubeotic cataract, retinal detachment, atrophy of the iris, microphthalmia, developing chronic eye infections, endothelial corneal dystrophy, perioperative complications (such as vitreous loss, hemorrhage…), foreseeable postoperative complications. WARNINGS: Physicians considering lens implantation under any of the following circumstances should weigh the potential risk/benefi t ratio: a. Recurrent severe anterior or posterior segment infl ammation or uveitis. b. Patients in whom the intraocular lens may affect the ability to observe, diagnose, or treat posterior segment diseases. c. Surgical diffi culties at the time of cataract extraction that might increase the potential for complications (e.g., persistent bleeding, signifi cant iris damage, uncontrolled positive pressure, or signifi cant vitreous prolapse or loss). d. A distorted eye due to previous trauma or developmental defect in which appropriate support of the IOL is not possible. e. Circumstances that would result in damage to the endothelium during implantation. f. Suspected microbial infection. g. Children under the age of 2 years are not suitable candidates for JOUSBPDVMBSMFOTFTI1BUJFOUTJOXIPNOFJUIFSUIFQPTUFSJPSDBQTVMFOPS[POVMFTBSFJOUBDUFOPVHIUPQSPWJEFTVQQPSUt4JODFUIFDMJOJDBMTUVEZGPSUIF"LSFPTJOUSBPDVMBSMFOTXBTDPOEVDUFEXJUIUIFMFOTCFJOHJNQMBOUFEJOUIFDBQTVMBSCBHPOMZUIFSFBSFJOTVGmDJFOUDMJOJDBMEBUBUPEFNPOTUSBUFJUTTBGFUZBOEFGmDBDZGPSQMBDFNFOU JOUIFDJMJBSZTVMDVTt*NQSPQFSIBOEMJOHPSGPMEJOHUFDIOJRVFTNBZDBVTFEBNBHFUPUIFIBQUJDPSPQUJDQPSUJPOTPG"LSFPTGPMEBCMFMFOTFT*GMFOTFTBSFOPUGPMEFEBDDPSEJOHUPEJSFDUJPOTPQUJDUFBSTNBZSFTVMU TFFi%JSFDUJPOTGPS6TFw 1IZTJDJBOTTIPVMEOPUBUUFNQUUPJNQMBOUMFOTFTUIBUIBWFSBEJBMPQUJDUFBSTPSTFQBSBUJPOT t6TFPGGPMEJOHJOTUSVNFOUTPUIFSUIBOUIPTFWBMJEBUFEBOESFDPNNFOEFEJOUIFMBCFMJOHNJHIUSFTVMUJO*0-EBNBHF PQUJDUFBSTIBQUJDEBNBHF UIBUNJHIUSFRVJSF*0-FYQMBOUBUJPOt5PBWPJEUIFDSFBUJPOPGQFSNBOFOUGPSDFQNBSLTJOUIFDFOUSBMPQUJD[POFFYFSDJTFDBSFEVSJOHIBOEMJOHBOEJOTFSUJPOPGUIFMFOT3FBEBOEGPMMPX the folding and insertion instructions carefully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y %POPUQMBDFUIFMFOTJODPOUBDUXJUITVSGBDFTXIFSFTVDIDPOUBNJOBUJPODBOPDDVS*GB:"(MBTFSQPTUFSJPSDBQTVMPUPNZJTQFSGPSNFEBTTVSFUIBUUIFMBTFSCFBNJTGPDVTFETMJHIUMZCFIJOEUIFQPTUFSJPSDBQTVMF"TXJUIBOZTVSHJDBMQSPDFEVSFUIFSFJTSJTLJOWPMWFE1PUFOUJBMBEWFSTFFWFOUTBOE complications accompanying cataract or implant surgery may include, but are not limited to the following: corneal endothelial damage, infection (endophthalmitis), retinal detachment, vitritis, cystoid macular edema, corneal edema, pupillary block, cyclitic membrane, iris prolapse, hypopyon, transient or persistent glaucoma and secondary surgical intervention. Secondary surgical interventions include, but are not limited to, lens repositioning, lens replacement, vitreous aspirations or iridectomy for pupillary block, wound leak repair, and retinal detachment repair. Amongst those directly related to the IOL are decentering and subluxation, precipitates on the surface of the IOL. Silicone oil, particularly when used in the surgical treatment of detached retina, may stick to the IOL if the posterior capsule of the crystalline lens is not intact.